COL6A1 and Wilson disease: In accordance with decreased number of CLS, eight weeks of CANA treatment significantly prevented WD-induced fibrosis in adipose tissue (Fig. 3e and f), associated with a reduced expression of Col6a1 and Col6a3 (Fig. 3g).